Clinical Trial Update: A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR) [NA]

View source ↗

Summary

A prospective clinical evaluation of the Total Vascular Access FLEX-1 device in chronic kidney disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: C. R. Bard | Conditions: Chronic Kidney Disease (CKD) | NA | Status: COMPLETED